Zai-Yong An, Ming-Zhe Liu, Jian-Yu Yuan, Meng-Yao Song, Xiao-Mei Yang, Yi He, Di Mu
{"title":"A Crh-defined insular cortex-brainstem-thalamic circuit regulates anxiety-related behavioral states.","authors":"Zai-Yong An, Ming-Zhe Liu, Jian-Yu Yuan, Meng-Yao Song, Xiao-Mei Yang, Yi He, Di Mu","doi":"10.1038/s41380-026-03950-4","DOIUrl":null,"url":null,"abstract":"<p><p>Anxiety disorders are among the most prevalent and debilitating psychiatric conditions, yet the neural circuits underlying anxiety-related states remain incompletely understood. Here we identify a cortical-brainstem-thalamic pathway in which Crh-expressing neurons in the anterior and middle insular cortex (a/mIC) engage the parabrachial nucleus (PBN), which in turn recruits the posterior paraventricular thalamic nucleus (pPVT) to contribute to anxiety-related behavior. Single-cell calcium imaging reveals that the predator odorant 2-methyl-2-thiazoline (2-MT) and footshock recruit partially overlapping populations of PBN-projecting a/mIC neurons; neurons activated by both stimuli exhibit increased activity during open-arm approach in the elevated plus maze. Exposure to 2-MT increases corticotropin-releasing factor (CRF) signals in the PBN, where CRF enhances PBN neuronal excitability and CRF receptor 1 (CRFR1) signaling facilitates a/mIC-terminal-evoked firing. Inhibition of Crh⁺ a/mIC-PBN projections, Crh knockdown in the a/mIC, or blockade of CRFR1 signaling within the PBN attenuates 2-MT-induced anxiety-like behavior. Human neuroimaging further reveals stronger functional coupling within a putative homologous aIC-PBN-pPVT network in individuals with anxiety symptoms, and the strength of this coupling correlates with anxiety severity. Together, these findings define a molecularly specified insular circuit that contributes to anxiety-related behavioral states.</p>","PeriodicalId":19008,"journal":{"name":"Molecular Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.4000,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41380-026-03950-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Anxiety disorders are among the most prevalent and debilitating psychiatric conditions, yet the neural circuits underlying anxiety-related states remain incompletely understood. Here we identify a cortical-brainstem-thalamic pathway in which Crh-expressing neurons in the anterior and middle insular cortex (a/mIC) engage the parabrachial nucleus (PBN), which in turn recruits the posterior paraventricular thalamic nucleus (pPVT) to contribute to anxiety-related behavior. Single-cell calcium imaging reveals that the predator odorant 2-methyl-2-thiazoline (2-MT) and footshock recruit partially overlapping populations of PBN-projecting a/mIC neurons; neurons activated by both stimuli exhibit increased activity during open-arm approach in the elevated plus maze. Exposure to 2-MT increases corticotropin-releasing factor (CRF) signals in the PBN, where CRF enhances PBN neuronal excitability and CRF receptor 1 (CRFR1) signaling facilitates a/mIC-terminal-evoked firing. Inhibition of Crh⁺ a/mIC-PBN projections, Crh knockdown in the a/mIC, or blockade of CRFR1 signaling within the PBN attenuates 2-MT-induced anxiety-like behavior. Human neuroimaging further reveals stronger functional coupling within a putative homologous aIC-PBN-pPVT network in individuals with anxiety symptoms, and the strength of this coupling correlates with anxiety severity. Together, these findings define a molecularly specified insular circuit that contributes to anxiety-related behavioral states.
期刊介绍:
Molecular Psychiatry focuses on publishing research that aims to uncover the biological mechanisms behind psychiatric disorders and their treatment. The journal emphasizes studies that bridge pre-clinical and clinical research, covering cellular, molecular, integrative, clinical, imaging, and psychopharmacology levels.